Collaborative Drug Discovery - About the company
Collaborative Drug Discovery is a series A company based in Burlingame (United States), founded in 2004. It operates as a Biological and chemical database to manage private and external data. Collaborative Drug Discovery has raised an undisclosed amount in funding. The company has 166 active competitors, including 22 funded and 15 that have exited. Its top competitors include companies like ESO, Sanguine and Giotto Technologies.
Company Details
Biological and chemical database to manage private and external data. Collaborative Drug Discovery offers CDD Vault - a biological and chemical database to manage private and external data securely. Users can organize chemical structures and biological study data, and collaborate with internal or external partners through web interface. It provides structure-aware tools for chemists and screening data tools for biologists. It allows users to selectively share data in real time with designated researchers claims to securely store experimental data in a private hosted vault and that it is protected with SSAE 16 Type II certified cloud storage on locked and guarded hardware.
- Website
- www.collaborativedrug.com/
- Registered Address
- Burlingame, California
Key Metrics
Founded Year
2004
Location
Burlingame, United States
Stage
Series A
Latest Funding Round
Ranked
18th among 166 active competitors
Employee Count
86 as on Jul 31, 2026
Legal entities associated with Collaborative Drug Discovery
Collaborative Drug Discovery is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
COLLABORATIVE DRUG DISCOVERY, INC. CIN: 421631574 , United States, Active | Dec 26, 999 | - | 43 (As on Dec 31, 2024) | - |
Sign up to download Collaborative Drug Discovery's company profile
Collaborative Drug Discovery's funding and investors
Collaborative Drug Discovery has raised funding over 16 rounds. Its first funding round was on 2005. Its latest funding round was a Grant (prize money) round on Apr 09, 2021 for $*****. 1 investor participated in its latest round. Collaborative Drug Discovery has 6 institutional investors.
Here is the list of recent funding rounds of Collaborative Drug Discovery:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 09, 2021 | 5468308 | Grant (prize money) | 9831272 | 5895025 | 1123936 | 2048591 |
Dec 19, 2019 | 7392993 | Grant (prize money) | 9082453 | 4743553 | 4977907 | |
Aug 15, 2019 | 1949808 | Grant (prize money) | 9053743 | 8549327 | 9153678 |
View details of Collaborative Drug Discovery's funding rounds and investors
Collaborative Drug Discovery's founders and board of directors
Founder? Claim ProfileCollaborative Drug Discovery's employee count trend
Collaborative Drug Discovery has 86 employees as of Jul 26. Here is Collaborative Drug Discovery's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Collaborative Drug Discovery's Competitors and alternates
Top competitors of Collaborative Drug Discovery include ESO, Sanguine and Giotto Technologies. Here is the list of Top 10 competitors of Collaborative Drug Discovery, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ESO 2004, Austin (United States), Series B | Provider of integrated software for emergency medical services | $50.4M | 61/100 | |
2nd | Sanguine 2010, Los Angeles (United States), Series B | Building a databank of patient-derived data for advanced research | $5.53M | 55/100 | |
3rd | Giotto Technologies 2017, Switzerland, Acquired | Developer of reasoning technology designed to advance artificial general intelligence | $5.02M | 54/100 | |
4th | ArcaScience 2018, Paris (France), Seed | Developer of AI models for patient-centric insights in drug development | $7M | 52/100 | |
5th | MDI 2018, Seattle (United States), Series A | AI-based medication management tool for healthcare professionals | $27M | 48/100 | |
6th | Biorelate 2014, Manchester (United Kingdom), Series A | Developer of an artificial intelligence platform for biomedical literature curation and knowledge graph construction | $8.74M | 47/100 | |
7th | ScienceIO 2020, Boston (United States), Acquired | Provider of AI solutions transforming medical text into enriched healthcare data | $8M | 46/100 | |
8th | KLAS 1996, Orem (United States), Unfunded | Healthcare data reports and insights provider | - | - | 45/100 |
9th | Kudos 2013, Oxford (United Kingdom), Series A | Provider of research communication and showcase services. It helps researchers effectively communicate their work to a broader audience. The company offers tools and resources to enhance research visibility and impact. Services include creating engaging narratives around research findings and facilitating their dissemination across various platforms. This improves the reach and understanding of scientific discoveries. | $2.5M | 45/100 | |
10th | Zotero 2007, Fairfax (United States), Unfunded | Research tool for collecting, organizing, citing, and sharing research | - | - | 45/100 |
18th | Collaborative Drug Discovery 2004, Burlingame (United States), Series A | Biological and chemical database to manage private and external data | - | 39/100 |
Looking for more details on Collaborative Drug Discovery's competitors? Click here to see the top ones
Collaborative Drug Discovery's Investments and acquisitions
Collaborative Drug Discovery has made no investments or acquisitions yet.
Reports related to Collaborative Drug Discovery
Here is the latest report on Collaborative Drug Discovery's sector:
News related to Collaborative Drug Discovery
•
•
Torx Software Announces Global Drug Discovery Collaboration with CDD VaultPharmaceutical Outsourcing•Sep 14, 2023•, Collaborative Drug Discovery
•
LAXAI Life Sciences Selects CDD Vault for Digital TransformationBusinessFortNight•Sep 12, 2023•LAXAI, Collaborative Drug Discovery
•
•
•
•
•
•
•
Are you a Founder ?
FAQs about Collaborative Drug Discovery
Explore our recently published companies
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company